Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD)

2020-01-30T11:27:30+00:00

Early Clinical Data Support ex vivo Hematopoietic Stem Cell Gene Therapy as a Potentially Promising Treatment Option for X-CGD BOSTON and LONDON, Jan. 29, 2020 [...]

Orchard Therapeutics Announces FDA Granted Orphan Drug Designation for OTL-102 for the Treatment of X-linked Chronic Granulomatous Disease (X-CGD)2020-01-30T11:27:30+00:00

Abcam and SomaServe announce comprehensive partnership to realise the potential of PolyNaut® ‘bionic’ nanoparticles for delivery to live cells

2019-12-17T11:56:35+00:00

Abcam plc, a global innovator in life science reagents and tools, and SomaServe Ltd, a Pharma service and specialist reagent business exploiting PolyNaut® Techn [...]

Abcam and SomaServe announce comprehensive partnership to realise the potential of PolyNaut® ‘bionic’ nanoparticles for delivery to live cells2019-12-17T11:56:35+00:00

SmartTarget software features on CBS News

2019-03-12T09:38:37+00:00

 Revolutionary technology developed at UCL Engineering that guides surgeons performing biopsies and improves prostate cancer detection has been featured on CBS [...]

SmartTarget software features on CBS News2019-03-12T09:38:37+00:00

UCL Spinout Hazy Features in Forbes

2018-11-29T12:25:16+00:00

AI spinout Hazy, featured in a recent Forbes list selecting the 15 Machine Learning Companies to Watch in Europe. Hazy made the top 10, for its platform that al [...]

UCL Spinout Hazy Features in Forbes2018-11-29T12:25:16+00:00